Challenges in using tumor mutational burden as a post-treatment biomarker

dc.contributor.authorTaban, H.
dc.contributor.authorErgun, Y.
dc.date.accessioned2025-02-22T14:09:02Z
dc.date.available2025-02-22T14:09:02Z
dc.date.issued2024
dc.departmentDicle Üniversitesien_US
dc.identifier.doi10.1016/j.esmoop.2024.103999
dc.identifier.issn2059-7029
dc.identifier.issue12en_US
dc.identifier.pmid39561622en_US
dc.identifier.scopusqualityQ1en_US
dc.identifier.urihttps://doi.org/10.1016/j.esmoop.2024.103999
dc.identifier.urihttps://hdl.handle.net/11468/29766
dc.identifier.volume9en_US
dc.identifier.wosWOS:001361612000001
dc.identifier.wosqualityQ1
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakPubMed
dc.language.isoenen_US
dc.publisherElsevieren_US
dc.relation.ispartofEsmo Openen_US
dc.relation.publicationcategoryDiğeren_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.snmzKA_WOS_20250222
dc.titleChallenges in using tumor mutational burden as a post-treatment biomarkeren_US
dc.typeLetteren_US

Dosyalar